Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950116-05-000951
Filing Date
2005-03-09
Accepted
2005-03-09 17:20:37
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 TENK.HTM tenk.htm 10-K 934661
2 GRAPHIC emptybox.gif GRAPHIC 1217
3 GRAPHIC tickedbox.gif GRAPHIC 1266
4 EX23-1.HTM ex23-1.htm EX-23 2021
5 EX31-1.HTM ex31-1.htm EX-31 7918
6 EX31-2,HTM ex31-2.htm EX-31 7850
7 EX32-1.HTM ex32-1.htm EX-32 3402
8 EX32-1.HTM ex32-2.htm EX-32 3398
  Complete submission text file 0000950116-05-000951.txt   964160
Mailing Address 1787 SENTRY PARKWAY WEST BUILDING 18 SUITE 440 BLUE BELL PA 19422
Business Address 1787 SENTRY PARKWAY WEST BUILDING 18 SUITE 440 BLUE BELL PA 19422 2152836850
INKINE PHARMACEUTICAL CO INC (Filer) CIK: 0000929547 (see all company filings)

EIN.: 133754005 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25572 | Film No.: 05670136
SIC: 2834 Pharmaceutical Preparations